We are a law firm dedicated to helping those injured by Medtronic Sprint Fidelis Defibrillator Lead.
Medtronic Recall Lawsuit
- Sprint Fidelis Lawsuit Status | Medtronic Recalls Heart Leads
- Medtronic Lead Recall Testimony | Sprint Fidelis News
- Medtronic Recall Lawsuit | Sprint Fidelis Defective Lead Attorney Lawyer
- Medtronic Heart Lead Recall | Class Action Lawsuit
- Sprint Fidelis Lead Recall 6930 Medtronic Lawsuit
- 6931 Medtronic Sprint Fidelis lead recall class action lawsuit
- Medtronic 6948 lead recall class action lawsuits
Medtronic Class Action Lead Recall
Helping people who have suffered side effects from defective Medtronic defibrillator leads and representing families who have lost a loved one in filing Medtronic class action lead recall lawsuits.
Fields Law Firm, is recognized as one of Minnesota’s most hard working and experienced personal injury law firms, solely devoting its practice to representing individuals who have been injured. The Medtronic lead recall attorneys at the Fields Law Firm are dedicated to protecting your interests and handling your Medtronic recall lawsuit with personal attention, aggressive advocacy, professionalism, and compassion.
All Medtronic Sprint Fidelis class action (MDL) cases have been transferred to federal court in Minneapolis, Minnesota. Medtronic is headquartered in Minnesota and we are in an ideal location for representing those injured by a defective Medtronic lead wire. Our office is located in Minneapolis, just down the street from the courthouse and judge assigned to oversee all of the Medtronic defective lead claims.
On October 15, 2007 Medtronic issued a recall of defective lead wires. This recall followed reports of at least five deaths related to the Medtronic defibrillator leads. It is estimated that the recalled leads have been implanted in 268,000 patients. In situations where a lead fractures or breaks, the lead can send false signals that cause unnecessary jolting defibrillator shocks or fail to deliver the appropriate electrical shock to a patient.
The Food & Drug Administration is recommending that patients who have had the defective Medtronic leads implanted should contact their doctor immediately, especially if they have experienced multiple shocks, lightheadedness, fainting or palpitations.
Defective Defibrillator
Medtronic’s Sprint Fidelis defibrillation leads were recalled because of the potential for lead fractures. Patients have experienced complications as a result of defective leads such as unnecessary shocks or jolts or not operating at all. In their October 15, 2007 letter to patients, Medtronic states that patients with a Sprint Fidelis lead “…are more likely to experience complications from removal than from a problem with a Sprint Fidelis lead”. This puts patients who have experienced problems or side effects in the difficult position of deciding whether to have the Medtronic leads removed or risk potential problems.
Medtronic Lead Recall
The following model numbers of the Sprint Fidelis family of defibrillator leads have been recalled:
• Sprint Fidelis 6930
• Sprint Fidelis 6931
• Sprint Fidelis 6948
• Sprint Fidelis 6949
Medtronic Class Action Lawsuit
The Medtronic class action lawsuits are being handled through what is called multidistrict litigation or “MDL”. All of the Medtronic recall cases have been consolidated and transferred to federal court in Minnesota where Medtronic is headquartered. Cases are still pursued individually. Multidistrict litigation only involves discovery matters and cases are returned to the original court in which they were filed after the completion of the discovery stage of the Medtronic litigation.
Back To Top
U.S. Food & Drug Administration Statement On Medtronic Sprint Fidelis Defibrillator
Medtronic Suspends Sprint Fidelis Defibrillation Leads (PDF)
U.S. FDA Class 1 Recall Report
If you or a loved one have been injured by the Medtronic Sprint Fidelis lead please contact us immediately. You may be entitled to compensation.
Following the Medtronic recall of their Sprint Fidelis leads the Food and Drug Administration (FDA) has been involved keeping patients informed of new information regarding the defective leads as it becomes available. The following Question and Answer sheet was released by the FDA to help consumers affected by the Medtronic lead recall.
Medtronic Recalls Sprint Fidelis […]
On June 11, 2008 Bridget Robb testified before the Senate Judiciary Committee regarding her experience with the Medtronic lead recall. Ms. Robb suffered 31 shocks as a result of a defective Sprint Fidelis lead manufactured by Medtronic. Ms. Robb tells her story and shows how important it is for manufacturers of dangerous and defective products to […]
Following the Medtronic recall of their Sprint Fidelis heart leads the FDA released a statement covering the background of the Medtronic leads and recommendations.
Neither the FDA, Medtronic, nor representatives of the Heart Rhythm Society, recommend the routine surgical removal of a fractured lead because removal carries risks. Instead, physicians should weigh the benefits and risks […]
On October 15, 2007, Medtronic, Inc. announced that it was recalling its Sprint Fidelis defibrillation leads. Medtronic announced that the recall was due to “the potential for lead fractures.” At the time of the recall, there were reports of at least five deaths associated with the defibrillator leads. The Food and Drug Administration classified the […]
As of October 2007, Medtronic was aware of at least 665 chronic fractures in returned Sprint Fidelis leads. The majority of these fractures (approximately 90%) have occurred in the anode or cathode conductors. The Medtronic Sprint Fidelis 6930 lead was included in the 2007 recall. There seems to be evidence that Medtronic has knowledge their […]
